Sigma Foods (SIGMAF) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 Apr, 2026Executive summary
Record 2025 revenues surpassed $9.273 billion, with EBITDA reaching $1 billion and double-digit ROIC sustained in a dynamic macro environment.
Strong performance was driven by diversified operations, selective price actions, and favorable FX, with Mexico and Europe leading growth.
Strategic focus on operational excellence, brand innovation, capacity expansion, and future-oriented innovation.
Completed the spin-off of Alpek, now reported as discontinued operations, and rebranded as Sigma Foods with new ticker and logo.
Financial highlights
4Q25 revenues reached $2.5 billion, up 13% year-over-year and 2% sequentially; full-year revenues up 4%.
4Q25 EBITDA was $278 million; comparable EBITDA was $284 million, up 34% year-over-year.
Net income in 4Q25 was $177 million, with full-year net income at $462 million, up from $52 million in 2024.
CapEx totaled $362 million for 2025, up 47% from 2024, reflecting capacity expansions and modernization.
Net Debt ended at $2.705 billion, Net Debt/EBITDA at 2.5x, and total liquidity at $1.5 billion.
Outlook and guidance
2026 guidance projects 4% revenue growth, 5–10% EBITDA growth, and 2% volume growth, with all regions contributing and double-digit growth in Europe.
CapEx for 2026 projected at $460 million, up 27%, mainly for capacity replacement in Spain and expansions in Mexico and the U.S.
Dividend proposal of $150 million for 2026, maintaining a 2.5x Net Debt/EBITDA target.
Latest events from Sigma Foods
- Record 4Q25 EBITDA, strong innovation, and sustainability progress drive growth outlook.SIGMAF
Corporate presentation25 Feb 2026 - EBITDA and guidance rose on Sigma's record results, with debt reduction and transformation progressing.SIGMAF
Q2 20242 Feb 2026 - Sigma posts record EBITDA as ALFA advances Alpek spin-off and targets lower leverage.SIGMAF
Q3 202418 Jan 2026 - Record results and transformation position for growth as Alpek spin-off nears completion.SIGMAF
Q4 202419 Dec 2025 - Record revenues and sequential EBITDA gains despite cost and operational headwinds.SIGMAF
Q3 202514 Dec 2025 - Transformation complete, 1Q25 EBITDA at US$220M, S&P upgrades to 'BBB'.SIGMAF
Q1 202529 Nov 2025 - Record 2Q25 revenues and EBITDA, with insurance gains and strategic transformation completed.SIGMAF
Q2 202513 Nov 2025